China Meheco Group Co., Ltd. (SHA:600056)

Market Cap	15.51B +5.1%
Revenue (ttm)	35.02B +0.1%
Net Income	482.86M -20.8%
EPS	0.32 -20.8%
Shares Out	1.50B
PE Ratio	32.12
Forward PE	n/a
Dividend	0.11 (1.01%)
Ex-Dividend Date	n/a

Volume	16,026,155
Average Volume	33,333,556
Open	10.37
Previous Close	10.37
Day's Range	10.32 - 10.41
52-Week Range	9.75 - 12.48
Beta	0.20
RSI	44.48
Earnings Date	Apr 25, 2026

About China Meheco Group

China Meheco Group Co., Ltd. engages in the manufacture, marketing, and trade of pharmaceuticals and medical devices in China and internationally. The company is involved in the planting and sale of Chinese medicinal materials, as well as the provision of related technical and warehousing services. Its drug products cover therapeutic fields, such as anti-infection, cardiovascular, hormones and endocrine regulation, respiratory and digestive systems, nutritional supplements, antipyretic analgesics, and other therapeutic areas as well as Chinese ...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1983
• Employees: 8,368
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600056

Financial Performance

In 2025, China Meheco Group's revenue was 35.36 billion, an increase of 3.55% compared to the previous year's 34.15 billion. Earnings were 473.23 million, a decrease of -11.62%.